3D Information and Biomedicine: How Artificial Intelligence/Machine Intelligence will contribute to Cancer Patient Care and Vaccine Design
Rutgers Cancer Institute of New JerseyInvestigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) explored how Artificial Intelligence/Machine Learning will complement existing approaches focused on genome-protein sequence information, including identifying mutations in human tumors published online December 2 in The New England Journal of Medicine.